Welcome to our dedicated page for Stryker SEC filings (Ticker: SYK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Stryker Corporation (NYSE: SYK) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, annual and quarterly reports, and other materials that describe Stryker’s financial condition, governance and material events as a global medical technologies company focused on MedSurg, Neurotechnology and Orthopaedics.
Current reports (Form 8-K) play a central role in Stryker’s disclosure practices. For example, the company has filed 8-Ks to furnish press releases announcing second and third quarter 2025 operating results, detailing net sales, segment performance and earnings metrics. Another Form 8-K dated December 4, 2025 reports leadership changes, including the appointment of a President and Chief Operating Officer and a new Group President, Orthopaedics, and summarizes related compensation arrangements.
Through its SEC filings, Stryker also identifies its registered securities and capital structure. Filings list the company’s common stock, traded on the New York Stock Exchange under the symbol SYK, along with multiple series of senior unsecured notes with different maturities that are also listed on the NYSE. These disclosures help investors understand the instruments available for investing in Stryker and the company’s obligations under its notes.
On Stock Titan, Stryker’s filings are updated in step with new submissions to the SEC’s EDGAR system. AI-powered tools summarize key points from lengthy documents, helping readers quickly identify items such as results of operations, leadership changes, segment commentary and descriptions of registered securities. Users can review Stryker’s historical and recent filings to track how the company reports on its MedSurg, Neurotechnology and Orthopaedics businesses, financial performance and governance over time.
Stryker Group President Dylan Bram Crotty reported a routine tax-related share disposition. On March 21, 2026, 368 shares of Stryker common stock were withheld at $335.67 per share to cover tax obligations, leaving 5,474 shares held directly. He also reports indirect holdings of 1,480 shares in a 401(k), 6,543 shares in a personal trust, and 313 shares each held for a daughter and son.
Stryker VP and Chief Accounting Officer William E. Berry Jr. reported a routine tax-related share disposition. On March 21, 2026, 176 shares of Stryker common stock were used at $335.67 per share to satisfy tax obligations, a non‑market transaction. After this, he holds 3,426 shares directly and 615 shares indirectly through a 401(k) plan.
Stryker Corporation calls a virtual 2026 annual meeting on May 6, 2026 at 12:00 p.m. Eastern, where shareholders will vote on electing ten directors, ratifying Ernst & Young LLP as independent auditor for 2026, and approving named executive officer compensation on an advisory basis.
Only holders of Stryker common stock as of March 9, 2026, when 382,984,253 shares were outstanding, may vote, using internet, phone, mail or the virtual platform. The board highlights strong governance practices, including majority voting with resignation policy, a robust Lead Independent Director, fully independent key committees and proxy access.
For 2025, Stryker reports net sales of $25,116 million versus $22,595 million in 2024, an 11.2% increase. Net earnings were $3,246 million, up 8.5%, with reported diluted EPS of $8.40. Adjusted net earnings reached $5,267 million and adjusted diluted EPS were $13.63, both up double digits. Dividends paid were $3.36 per share, up 5.0%.
The company emphasizes pay-for-performance, noting that for 2025 variable and stock-based pay for named executive officers averaged 87% of total direct compensation, and its 2025 say-on-pay vote received approximately 92% support. Extensive detail is provided on board composition, risk oversight, compensation design, non-GAAP reconciliations and shareholder proposal procedures for 2027.
Stryker Corporation provides an update on a previously disclosed cybersecurity incident that disrupted its corporate network, including parts of its Microsoft environment. Working with Palo Alto Networks’ Unit 42, third-party experts, and law enforcement, Stryker reports the incident is believed to be contained.
Current forensic analysis has not identified malicious activity directed toward customers, suppliers, vendors, or partners, nor evidence that the threat actor accessed their systems as a result of this incident. Stryker is prioritizing restoration of systems that support ordering, shipping, and manufacturing, which it says are ramping back up, while it continues to assess whether the incident is reasonably likely to have a material operational or financial impact.
Stryker Corporation reports an ongoing cybersecurity incident that disrupted its global Microsoft environment and is affecting order processing, manufacturing and shipping. The company currently believes its patient-related services have not been disrupted and its connected products were not impacted.
An internal investigation continues, and the full scope, nature and operational or financial impacts are not yet known. Stryker also highlights potential risks including data integrity issues, regulatory scrutiny, litigation, reputational damage and adverse effects on revenue, operating income, cash flows and liquidity.
Stryker Corporation reported a cybersecurity incident that disrupted its global Microsoft-based information technology environment. After detecting the issue on March 11, 2026, the company activated its cybersecurity response plan, brought in external advisors and experts, and believes the incident is currently contained with no indication of ransomware or malware.
The disruption is limiting access to certain information systems and business applications that support Stryker’s operations and corporate functions, and a full restoration timeline is still unknown. Stryker is using business continuity measures to keep serving customers, while an ongoing investigation evaluates the scope, operational effects, and any financial impact. The company has not yet determined whether the incident is reasonably likely to have a material impact.
Stryker Corp Chair and CEO Kevin Lobo received an equity award of 50,332 shares of Common Stock on March 9, 2026 as a grant/award acquisition. The award was earned upon achieving pre-set three-year adjusted diluted net earnings per share goals and sales performance goals, and the earned shares vest on March 21, 2026.
After this award, Lobo directly holds 247,271 shares of Stryker common stock and indirectly holds 721 shares through a 401(k) plan. A one‑share adjustment corrected a previously reported balance related to an earlier option exercise and associated tax withholding.
Stryker Corporation reported that VP and Chief HR Officer M. Kathryn Fink received a grant of 5,220 shares of common stock on March 9, 2026 as a compensation award at $0.00 per share. The award was earned upon achievement of pre-established three-year adjusted diluted net earnings per share and sales performance goals, and the earned shares vest on March 21, 2026. Following this award, Fink directly holds 18,551 shares, with additional indirect holdings of 422 shares through a 401(k) plan and 177 shares through the 2023 Mary Fink Living Trust. The direct holdings include 128 shares acquired under Stryker's Employee Stock Purchase Plan as of December 31, 2025.
Fletcher Robert S reported acquisition or exercise transactions in this Form 4 filing.
STRYKER CORP VP and Chief Legal Officer Robert S. Fletcher reported an equity award of 7,828 shares of Common Stock. The shares were granted at no cash cost as compensation after the achievement of pre-established three-year adjusted diluted net earnings per share and sales performance goals, and will vest on March 21, 2026. Following this award, he directly holds 18,285 common shares, and indirectly holds 162 shares through a 401(k) plan.
STRYKER CORP Group President Viju Menon reported a compensation-related stock award, not an open-market purchase. He acquired 9,320 shares of common stock at no cost as a grant tied to pre-established three-year adjusted diluted net earnings per share and sales performance goals.
The earned shares are scheduled to vest on March 21, 2026. Following this grant, Menon holds 21,831 shares directly and 198 shares indirectly through a 401(k) plan, giving a clearer picture of his overall equity stake in the company.